from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0155/pntAa

LFCtreatmentdescriptionclass of inhibitor

0.152

Amikacinug/mL Amikacintranslation

0.485

Cap5-10ug/mL Capreomycintranslation

0.109

Rox10-50 ug/mL Roxithromycintranslation

0.609

SM2-5 ug/mL Streptomycintranslation

0.279

Tet5-10 ug/mL Tetracyclinetranslation

-0.295

Rif0.2-5ug/mL Rifampicintranscription

0.258

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.290

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.095

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.135

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.236

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.290

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.734

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.357

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-2.048

Nigericin50 uM Nigericinrespiration

-0.800

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.114

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.434

menadione6-10 ug/mL Menadionerespiration

-1.341

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.437

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.789

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.032

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.912

NRP_1Non-replicating persistence stage 1dosRassociated

0.194

Amp0.2mg/mL AmpicillincellWall

0.528

Cephalexin20-100 ug/mL CephalexincellWall

0.842

Cerulenin0.32-5 ug/mL CerulenincellWall

0.282

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.483

EMB10-20 ug/mL EthambutolcellWall

0.936

Eta12-40 ug/mL EthionamidecellWall

1.308

INH0.2-0.4 ug/mL IsoniazidcellWall

0.456

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.905

BZA0.12 mg/mL BenzamidearomaticAmides

0.068

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.082

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.140

H2O24 mM hydrogen peroxideDNAdamaging

0.137

Levo10 ug/mL LevofloxacinDNAdamaging

0.627

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.491

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.803

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.266

Antimycin12.5-50 ug/mL Antimycin A?

-0.503

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.226

PA_110-50 ug/mL Antitubercular compound PA-1?

0.145

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.111

PA8240.2-2 ug/mL PA-824?

-1.462

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.678

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

-0.850

mercaptoethanol2 mM 2-Mercaptoethanol?

0.424

methoxatin10-20 ug/mL Methoxatin?